This yielded a single, well-defined, multifunctional STING agonist that increased tumor accumulation in a PD-L1-dependent manner, while also blocking an important immune checkpoint, resulting in spontaneous induction of tumor antigen-specific T cells that inhibited tumor growth and provided immunological memory that protected against tumor rechallenge. The gene discussed is STING1; the disease is neoplasm.